Disclosure? It's Not Good Enough

In compliance with a federal integrity agreement, pharmaceutical giant Pfizer has just released details of its financial involvement with the medical community.

According to the New York Times, the drug maker disclosed that it paid $20 million in consulting and speaking fees to 4,500 doctors in the second half of 2009. The company also shelled out $15.3 million to U.S. academic medical centers for their clinical trials.

A few other drug makers have disclosed their doctor payments in the past...